About
Technology
Issues
FAQ
Links
Official Page
Phase I/II study with ruthenium compound NAMI-A and gemcitabine in patients with non-small cell lung cancer after first line therapy
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.